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A patient presented with spells of light-headedness, confusion and collapses, improving on 
eating. During a supervised fast, plasma glucose dropped to 1·7 mmol/L, with inappropriately 
high insulin, raised C-peptide and no sulphonylurea detectable, diagnostic of an insulinoma 
[1]. 
 
CT, MRI and abdominal ultrasound scanning failed to find any evidence of a lesion in the 
pancreas and all showed a liver lesion (a: black arrow). Somatostatin subtype 2 (sst2) receptor 
imaging with 68Ga-DOTATATE PET/CT was normal (b). The white arrow shows the body of 
pancreas in each panel. 
 
Glucagon-like peptide-1 (GLP-1) receptor SPECT/CT was performed. This showed strong 
focal uptake posteriorly within the pancreatic body (c: white arrow). Notably, the liver lesion 
did not show any uptake. The pancreatic lesion was enucleated and the liver lesion was 
excised. Histopathology showed a well differentiated insulinoma in the pancreas. The liver 
lesion proved to be a metastasis from a salivary gland-type lung tumour, previously resected 
in 2008. The insulinoma was found on autoradiography in vitro to express GLP-1 receptors 
but not sst2 receptors. 
 
GLP-1 is a gut hormone that stimulates insulin release from beta cells and represses glucagon 
release from alpha cells. 111In-labeled exendin-4 is a GLP-1 analogue, and can be used to 
image tissues that express GLP-1 receptors in high density [2-4]. In a prospective study, GLP-
1 receptor imaging correctly located all six insulinomas preoperatively [2]. This new imaging 
modality may therefore be useful in locating small and occult tumours to guide surgery and to 
distinguish them from co-incident lesions. 
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